In the analyses stratified by tumor ER status (Table 3), the difference in the association of BMI with breast cancer risk by p-mTOR expression status was significant among women with ER+ tumors (P-heterogeneity = 0.015), but not those with ER– tumors. The gene discussed is MTOR; the disease is breast carcinoma.